We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$130B
$130B $513.26 0.27%
REGN icon
2
Regeneron Pharmaceuticals
REGN
$79.7B
$79.7B $774.61 0.06%
ARGX icon
3
argenx
ARGX
$61.6B
$61.6B $984.69 0.5%
MRNA icon
4
Moderna
MRNA
$58.1B
$58.1B $145.62 1.29%
RVMD icon
5
Revolution Medicines
RVMD
$42B
$42B $195.92 4.36%
ONC
6
BeOne Medicines Ltd
ONC
$39.4B
$39.4B $348.08 0.46%
ALNY icon
7
Alnylam Pharmaceuticals
ALNY
$32B
$32B $239.36 0.46%
ROIV icon
8
Roivant Sciences
ROIV
$28.6B
$28.6B $39.57 0.18%
INSM icon
9
Insmed
INSM
$26.8B
$26.8B $122.58 2.22%
RPRX icon
10
Royalty Pharma
RPRX
$26B
$26B $58.47 0%
INCY icon
11
Incyte
INCY
$25.3B
$25.3B $124.75 2.47%
BNTX icon
12
BioNTech
BNTX
$24.1B
$24.1B $95.83 0.89%
GMAB icon
13
Genmab
GMAB
$21.2B
$21.2B $34.40 0.73%
ASND icon
14
Ascendis Pharma A/S
ASND
$16.3B
$16.3B $247.69 3.3%
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$15.8B
$15.8B $243.59 1.15%
EXEL icon
16
Exelixis
EXEL
$14.1B
$14.1B $56.78 0.21%
SMMT icon
17
Summit Therapeutics
SMMT
$13.8B
$13.8B $17.30 0.57%
BBIO icon
18
BridgeBio Pharma
BBIO
$13.4B
$13.4B $68.30 0.13%
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$12.5B
$12.5B $64.73 0.43%
HALO icon
20
Halozyme
HALO
$12.3B
$12.3B $108.44 2.06%
MDGL icon
21
Madrigal Pharmaceuticals
MDGL
$12.2B
$12.2B $529.09 1.11%
CORT icon
22
Corcept Therapeutics
CORT
$12.1B
$12.1B $111.81 0.89%
TECH icon
23
Bio-Techne
TECH
$11.3B
$11.3B $72.33 0.01%
AXSM icon
24
Axsome Therapeutics
AXSM
$11.1B
$11.1B $211.97 3.87%
KRSA
25
Korsana Biosciences, Inc. Common Stock
KRSA
$10.1B
$10.1B $31.23 2.65%
1
2 3 4 5

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.